Back to Search Start Over

Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression.

Authors :
Sebastián VP
Salazar GA
Coronado-Arrázola I
Schultz BM
Vallejos OP
Berkowitz L
Álvarez-Lobos MM
Riedel CA
Kalergis AM
Bueno SM
Source :
Frontiers in immunology [Front Immunol] 2018 Sep 12; Vol. 9, pp. 1956. Date of Electronic Publication: 2018 Sep 12 (Print Publication: 2018).
Publication Year :
2018

Abstract

Heme Oxygenase 1 (HMOX1) is an enzyme that catalyzes the reaction that degrades the heme group contained in several important proteins, such as hemoglobin, myoglobin, and cytochrome p450. The enzymatic reaction catalyzed by HMOX1 generates Fe <superscript>2+</superscript> , biliverdin and CO. It has been shown that HMOX1 activity and the by-product CO can downmodulate the damaging immune response in several models of intestinal inflammation as a result of pharmacological induction of HMOX1 expression and the administration of non-toxic amounts of CO. Inflammatory Bowel Diseases, which includes Crohn's Disease (CD) and Ulcerative Colitis (UC), are one of the most studied ailments associated to HMOX1 effects. However, microbiota imbalances and infections are also important factors influencing the occurrence of acute and chronic intestinal inflammation, where HMOX1 activity may play a major role. As part of this article we discuss the immune modulatory capacity of HMOX1 during IBD, as well during the infections and interactions with the microbiota that contribute to this inflammatory disease.

Details

Language :
English
ISSN :
1664-3224
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
30258436
Full Text :
https://doi.org/10.3389/fimmu.2018.01956